Medical division: Foliumed Bogotá, Colombia
History
We started the application process for cultivation, extraction and export licences for psychoactive and non-psychoactive cannabis (CBD) in Q4 2017. Our decision to locate our medical division in Colombia has been based upon the country’s unique growing conditions, the availability of highly skilled human resources and a favorable, export- oriented regulatory framework.
Growth strategy
Following licence approval in Q3 2018, we will build out our 14 hectare cultivation and GMP extraction site in close proximity to Bogota. Our commercial strategy is to provide affordable, efficacy-proven prescription medicines and innovative OTC products to:
Latin America
a market with
625 M people
where high cost LPs won’t be able to compete.
Major regulated import
markets such as
Germany or Canada
where demand outstrips supply
Facts and figures
Total cultivation capacity:
54 tons
of dried flower per annum
Total oil extraction capacity:
15 tons
of oil per annum